A detailed history of Impax Asset Management Group PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Impax Asset Management Group PLC holds 5,470,174 shares of BSX stock, worth $498 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
5,470,174
Previous 5,470,174 -0.0%
Holding current value
$498 Million
Previous $458 Million -0.0%
% of portfolio
1.99%
Previous 2.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$72.96 - $84.0 $59.5 Million - $68.5 Million
815,403 Added 17.52%
5,470,174 $458 Million
Q2 2024

Nov 08, 2024

SELL
$67.33 - $77.71 $54.9 Million - $63.4 Million
-815,403 Reduced 14.91%
4,654,771 $358 Million
Q2 2024

Aug 05, 2024

BUY
$67.33 - $77.71 $12.8 Million - $14.7 Million
189,705 Added 4.25%
4,654,771 $358 Million
Q1 2024

Apr 30, 2024

BUY
$57.6 - $68.62 $7.09 Million - $8.44 Million
123,021 Added 2.83%
4,465,066 $306 Million
Q4 2023

Jan 26, 2024

BUY
$48.64 - $57.81 $3.89 Million - $4.63 Million
80,071 Added 1.88%
4,342,045 $251 Million
Q3 2023

Nov 07, 2023

SELL
$50.19 - $54.68 $89.1 Million - $97 Million
-1,774,667 Reduced 29.4%
4,261,974 $225 Million
Q2 2023

Aug 07, 2023

SELL
$49.72 - $54.64 $46.8 Million - $51.5 Million
-941,770 Reduced 13.5%
6,036,641 $327 Million
Q1 2023

May 10, 2023

SELL
$45.09 - $50.03 $2.03 Million - $2.25 Million
-45,023 Reduced 0.64%
6,978,411 $349 Million
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $15.9 Million - $19 Million
402,301 Added 6.08%
7,023,434 $325 Million
Q3 2022

Nov 08, 2022

BUY
$36.71 - $109.66 $78.3 Million - $234 Million
2,132,468 Added 47.51%
6,621,133 $256 Million
Q2 2022

Aug 11, 2022

BUY
$35.24 - $47.1 $158 Million - $211 Million
4,488,665 New
4,488,665 $167 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.